Cosciens Biopharma Stock Alpha and Beta Analysis

CSCI Stock   2.91  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as COSCIENS Biopharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in COSCIENS Biopharma over a specified time horizon. Remember, high COSCIENS Biopharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to COSCIENS Biopharma's market risk premium analysis include:
Beta
0.28
Alpha
(0.48)
Risk
3.14
Sharpe Ratio
(0.17)
Expected Return
(0.53)
Please note that although COSCIENS Biopharma alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, COSCIENS Biopharma did 0.48  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of COSCIENS Biopharma stock's relative risk over its benchmark. COSCIENS Biopharma has a beta of 0.28  . As returns on the market increase, COSCIENS Biopharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding COSCIENS Biopharma is expected to be smaller as well. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out COSCIENS Biopharma Backtesting, COSCIENS Biopharma Valuation, COSCIENS Biopharma Correlation, COSCIENS Biopharma Hype Analysis, COSCIENS Biopharma Volatility, COSCIENS Biopharma History and analyze COSCIENS Biopharma Performance.
For more detail on how to invest in COSCIENS Stock please use our How to Invest in COSCIENS Biopharma guide.

COSCIENS Biopharma Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. COSCIENS Biopharma market risk premium is the additional return an investor will receive from holding COSCIENS Biopharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in COSCIENS Biopharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate COSCIENS Biopharma's performance over market.
α-0.48   β0.28

COSCIENS Biopharma expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of COSCIENS Biopharma's Buy-and-hold return. Our buy-and-hold chart shows how COSCIENS Biopharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

COSCIENS Biopharma Market Price Analysis

Market price analysis indicators help investors to evaluate how COSCIENS Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading COSCIENS Biopharma shares will generate the highest return on investment. By understating and applying COSCIENS Biopharma stock market price indicators, traders can identify COSCIENS Biopharma position entry and exit signals to maximize returns.

COSCIENS Biopharma Return and Market Media

The median price of COSCIENS Biopharma for the period between Wed, Sep 18, 2024 and Tue, Dec 17, 2024 is 3.7 with a coefficient of variation of 12.09. The daily time series for the period is distributed with a sample standard deviation of 0.42, arithmetic mean of 3.5, and mean deviation of 0.37. The Stock received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
Aeterna Zentaris Research Coverage Started at StockNews.com
09/25/2024
2
Aeterna Zentaris Coverage Initiated at StockNews.com
10/17/2024

About COSCIENS Biopharma Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including COSCIENS or other stocks. Alpha measures the amount that position in COSCIENS Biopharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards COSCIENS Biopharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, COSCIENS Biopharma's short interest history, or implied volatility extrapolated from COSCIENS Biopharma options trading.

Build Portfolio with COSCIENS Biopharma

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether COSCIENS Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of COSCIENS Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cosciens Biopharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cosciens Biopharma Stock:
COSCIENS Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of COSCIENS Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of COSCIENS Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...